Independent Research GmbH Upgrades Pfizer (PFE) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500 set for muted open after big bank earnings, chip slide weighs
- Oil eases as traders monitor Russian diesel deal, Saudi attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Tweet
Share
E-mailGet Alerts PFE Hot Sheet
Price: $28.40 --0%
Rating Summary:
14 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 16 | New: 33
Rating Summary:
14 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 16 | New: 33
Join SI Premium – FREE
Independent Research GmbH analyst Tobias Gottschalt upgraded Pfizer (NYSE: PFE) from Hold to Buy with a price target of $54.00 (from $51.00).
For an analyst ratings summary and ratings history on Pfizer click here. For more ratings news on Pfizer click here.
Shares of Pfizer closed at $49.02 yesterday.
You May Also Be Interested In
- Guggenheim Reiterates Buy Rating on Pfizer (PFE)
- Nurix (NRIX) PT Lowered to $33 at Truist Securities
- CLSA Upgrades RHB Bank (RHBBANK:MK) to Outperform (2)
Create E-mail Alert Related Categories
Analyst PT Change, Hot Upgrades, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
